subscribeSubscribe
Novartis` Prometax (rivastigmine) Receives Approval in Europe

Novartis` Prometax (rivastigmine) Receives Approval in Europe
EMA
08 Jun 2023
Share Share
Luye Pharma`s Rivastigmine Transdermal Patch Receives Market Approval in China

Luye Pharma`s Rivastigmine Transdermal Patch Receives Market Approval in China
PRESS RELEASE
08 Jun 2020
Share Share
People often skip neurological meds when out-of-pocket costs rise

People often skip neurological meds when out-of-pocket costs rise
Linda Carroll REUTERS
20 Feb 2020
Share Share
Zydus Noveltech`s Generic Rivastigmine Receives Approval in US

Zydus Noveltech`s Generic Rivastigmine Receives Approval in US
FDA
06 Mar 2019
Share Share
Luye Pharma receives China approval for CNS drug

Luye Pharma receives China approval for CNS drug
BIOSPECTRUM
23 Jul 2018
Share Share
Mylan launches generic drug-delivery patch for dementia patients

Mylan launches generic drug-delivery patch for dementia patients
Sarah Faulkner DRUG DEL BUSINESS
09 Jul 2018
Share Share
Mylan Technologies Generic Rivastigmine Receives Approval In US

Mylan Technologies Generic Rivastigmine Receives Approval In US
FDA
26 Jun 2018
Share Share
Dementia prescriptions six times higher than a decade ago

Dementia prescriptions six times higher than a decade ago
Selina McKee PHARMATIMES
19 Jan 2016
Share Share
Novartis, Allergan Alzheimer`s meds linked to abnormal behavior

Novartis, Allergan Alzheimer`s meds linked to abnormal behavior
Emily Wasserman FIERCE PHARMA
10 Oct 2015
Share Share
Generic alternative to Novartis` transdermal patch for Alzheimer`s hits the market

Generic alternative to Novartis` transdermal patch for Alzheimer`s hits the market
Varun Saxena FIERCE DRUG DELIVERY
09 Sep 2015
Share Share